GB201808839D0 - Method of predicting survival rates for cancer patients - Google Patents
Method of predicting survival rates for cancer patientsInfo
- Publication number
- GB201808839D0 GB201808839D0 GBGB1808839.3A GB201808839A GB201808839D0 GB 201808839 D0 GB201808839 D0 GB 201808839D0 GB 201808839 A GB201808839 A GB 201808839A GB 201808839 D0 GB201808839 D0 GB 201808839D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cancer patients
- survival rates
- predicting survival
- predicting
- rates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1808839.3A GB201808839D0 (en) | 2018-05-30 | 2018-05-30 | Method of predicting survival rates for cancer patients |
| PCT/GB2019/051464 WO2019229431A1 (en) | 2018-05-30 | 2019-05-29 | Method of predicting survival rates for oropharyngeal cancer patients |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1808839.3A GB201808839D0 (en) | 2018-05-30 | 2018-05-30 | Method of predicting survival rates for cancer patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB201808839D0 true GB201808839D0 (en) | 2018-07-11 |
Family
ID=62812233
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB1808839.3A Ceased GB201808839D0 (en) | 2018-05-30 | 2018-05-30 | Method of predicting survival rates for cancer patients |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB201808839D0 (en) |
| WO (1) | WO2019229431A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20080133141A1 (en) | 2005-12-22 | 2008-06-05 | Frost Stephen J | Weighted Scoring Methods and Use Thereof in Screening |
| US20130303826A1 (en) * | 2011-01-11 | 2013-11-14 | University Health Network | Prognostic signature for oral squamous cell carcinoma |
| MX352642B (en) | 2011-11-15 | 2017-12-01 | Univ Miami | METHODS FOR DETECTING HUMAN PAPILOMAVIRUS AND PROVIDING FORECAST FOR CARCINOMA OF SCAMOUS CELLS OF HEAD AND NECK. |
| US9809857B2 (en) | 2013-02-28 | 2017-11-07 | Washington University | Methods and signatures for oropharyngeal cancer prognosis |
| US20160025729A1 (en) * | 2014-07-25 | 2016-01-28 | OncoGenesis Inc. | Systems And Methods For Early Detection Of Cervical Cancer By Multiplex Protein Biomarkers |
| WO2016094330A2 (en) | 2014-12-08 | 2016-06-16 | 20/20 Genesystems, Inc | Methods and machine learning systems for predicting the liklihood or risk of having cancer |
-
2018
- 2018-05-30 GB GBGB1808839.3A patent/GB201808839D0/en not_active Ceased
-
2019
- 2019-05-29 WO PCT/GB2019/051464 patent/WO2019229431A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2019229431A1 (en) | 2019-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL308805B2 (en) | Anti-pd-1 antibodies for treatment of lung cancer | |
| IL266847A (en) | Methods for treatment of cancer comprising tigit-binding agents | |
| GB201901439D0 (en) | Method of predicting survival rates for cancer patients | |
| EP3201360A4 (en) | Methods for assessing risk of developing breast cancer | |
| IL285807A (en) | Immunotherapy for the treatment of cancer | |
| ZA201908539B (en) | Method of treatment of cancer | |
| ZA201808647B (en) | Methods for predicting therapeutic benefit of anti-cd19 therapy in patients | |
| EP3298145A4 (en) | Method of diagnosis of breast cancer | |
| HUE054420T2 (en) | Continuous process for reducing heterogeneity of therapeutic protein | |
| GB201908591D0 (en) | Methods for cancer diagnosis | |
| GB201717945D0 (en) | Method for treatment of cancer | |
| IL278982A (en) | Method for stratifying ibs patients | |
| IL287135A (en) | Methods of anti-tumor therapy | |
| IL289201A (en) | Compounds for treatment of cancer | |
| ZA202107342B (en) | Chiauranib for treatment of small cell lung cancer | |
| SI3794148T1 (en) | Methods for the diagnosis of aneurysm or cancer | |
| PL3792296T3 (en) | Method for the synthesis of polyethers | |
| GB201820098D0 (en) | Methods of cancer treatment | |
| SG11202011434SA (en) | Methods for the treatment of bladder cancer | |
| GB201808839D0 (en) | Method of predicting survival rates for cancer patients | |
| GB201914079D0 (en) | Method of predicting requirement for biologic therapy | |
| GB201820975D0 (en) | Methods of cancer treatment | |
| IL286198A (en) | Methods of anti-tumor therapy | |
| GB201817651D0 (en) | Method for predicting effectiveness of treatments for cancer patients | |
| HK40056430A (en) | Method of improving prediction of response for cancer patients treated with immunotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |